2013
Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures.
Bell ML, McKenzie JE. 2013. Designing psycho-oncology randomised trials and cluster randomised trials: variance components and intra-cluster correlation of commonly used psychosocial measures. Psychooncology. 22:1738–47. doi:10.1002/pon.3205.
ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma.
Nagle RB, Algotar AM, Cortez CC, Smith K, Jones C, Sathyanarayana UG, Yun S, Riley J, Nagy D, Dittamore R, et al. 2013. ERG overexpression and PTEN status predict capsular penetration in prostate carcinoma. Prostate. 73:1233–40. doi:10.1002/pros.22675.
Functional activation of ATM by the prostate cancer suppressor NKX3.1.
Bowen C, Ju J-H, Lee J-H, Paull TT, Gelmann EP. 2013. Functional activation of ATM by the prostate cancer suppressor NKX3.1. Cell Rep. 4:516–29. doi:10.1016/j.celrep.2013.06.039.
Skin cancer preventive behavior and sun protection recommendations.
Cooley JH, Quale LM. 2013. Skin cancer preventive behavior and sun protection recommendations. Semin Oncol Nurs. 29:223–6. doi:10.1016/j.soncn.2013.06.008.
Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
Belzer M, Morales M, Jagadish B, Mash EA, Wright SH. 2013. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2. J Pharmacol Exp Ther. 346:300–10. doi:10.1124/jpet.113.203257.
Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer.
Meenach SA, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. 2013. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. Eur J Pharm Sci. 49:699–711. doi:10.1016/j.ejps.2013.05.012.
The effect of psychosocial interventions delivered by telephone and videophone on quality of life in early-stage breast cancer survivors and their supportive partners.
Badger T, Segrin C, Pasvogel A, López AM. 2013. The effect of psychosocial interventions delivered by telephone and videophone on quality of life in early-stage breast cancer survivors and their supportive partners. J Telemed Telecare. 19:260–5. doi:10.1177/1357633X13492289.
Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1.
Cen B, Mahajan S, Wang W, Kraft AS. 2013. Elevation of receptor tyrosine kinases by small molecule AKT inhibitors in prostate cancer is mediated by Pim-1. Cancer Res. 73:3402–11. doi:10.1158/0008-5472.CAN-12-4619.
Far upstream element binding protein 1: a commander of transcription, translation and beyond.
Zhang J, Chen QM. 2013. Far upstream element binding protein 1: a commander of transcription, translation and beyond. Oncogene. 32:2907–16. doi:10.1038/onc.2012.350.
Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.
Miller JA, Lang JE, Ley M, Nagle R, Hsu C-H, Thompson PA, Cordova C, Waer A, Chow H-HS. 2013. Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer. Cancer Prev Res (Phila). 6:577–84. doi:10.1158/1940-6207.CAPR-12-0452.
Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA.
Woo H-H, Baker T, Laszlo C, Chambers SK. 2013. Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA. Mol Cell Proteomics. 12:1661–77. doi:10.1074/mcp.M112.025288.
Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B.
Torres MA, Pace TW, Liu T, Felger JC, Mister D, Doho GH, Kohn JN, Barsevick AM, Long Q, Miller AH. 2013. Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B. Cancer. 119:1951–9. doi:10.1002/cncr.28003.
Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo.
Escalante AM, McGrath RT, Karolak MR, Dorr RT, Lynch RM, Landowski TH. 2013. Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivo. Cancer Chemother Pharmacol. 71:1567–76. doi:10.1007/s00280-013-2156-3.
Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors.
Berglund E, Berglund D, Akcakaya P, Ghaderi M, Daré E, Berggren P-O, Köhler M, Aspinwall CA, Lui W-O, Zedenius J, et al. 2013. Evidence for Ca(2+)-regulated ATP release in gastrointestinal stromal tumors. Exp Cell Res. 319:1229–38. doi:10.1016/j.yexcr.2013.03.001.
Inositol pyrophosphates regulate cell growth and the environmental stress response by activating the HDAC Rpd3L.
Worley J, Luo X, Capaldi AP. 2013. Inositol pyrophosphates regulate cell growth and the environmental stress response by activating the HDAC Rpd3L. Cell Rep. 3:1476–82. doi:10.1016/j.celrep.2013.03.043.
Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart.
Lencinas A, Chhun DC, Dan KP, Ross KD, Hoover EA, Antin PB, Runyan RB. 2013. Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart. Dis Model Mech. 6:632–42. doi:10.1242/dmm.010595.
Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners.
Badger TA, Segrin C, Hepworth JT, Pasvogel A, Weihs K, López AM. 2013. Telephone-delivered health education and interpersonal counseling improve quality of life for Latinas with breast cancer and their supportive partners. Psychooncology. 22:1035–42. doi:10.1002/pon.3101.
Time trends and geographic variation in use of minimally invasive breast biopsy.
Zimmermann CJ, Sheffield KM, Duncan CB, Han Y, Cooksley CD, Townsend CM, Riall TS. 2013. Time trends and geographic variation in use of minimally invasive breast biopsy. J Am Coll Surg. 216:814–24; discussion 824. doi:10.1016/j.jamcollsurg.2012.12.007.
Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis.
Wright LE, Frye JB, Lukefahr AL, Timmermann BN, Mohammad KS, Guise TA, Funk JL. 2013. Curcuminoids block TGF-β signaling in human breast cancer cells and limit osteolysis in a murine model of breast cancer bone metastasis. J Nat Prod. 76:316–21. doi:10.1021/np300663v.
Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics.
Cance WG, Kurenova E, Marlowe T, Golubovskaya V. 2013. Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics. Sci Signal. 6:pe10. doi:10.1126/scisignal.2004021.
Environmental arsenic exposure and serum matrix metalloproteinase-9.
Burgess JL, Kurzius-Spencer M, O’Rourke MK, Littau SR, Roberge J, Meza-Montenegro MM, Gutiérrez-Millán LE, Harris RB. 2013. Environmental arsenic exposure and serum matrix metalloproteinase-9. J Expo Sci Environ Epidemiol. 23:163–9. doi:10.1038/jes.2012.107.
Epigenetic field defects in progression to cancer.
Bernstein C, Nfonsam V, Prasad AR, Bernstein H. 2013. Epigenetic field defects in progression to cancer. World J Gastrointest Oncol. 5:43–9. doi:10.4251/wjgo.v5.i3.43.
Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking.
Fritz BG, Roberts SA, Ahmed A, Breci L, Li W, Weichsel A, Brailey JL, Wysocki VH, Tama F, Montfort WR. 2013. Molecular model of a soluble guanylyl cyclase fragment determined by small-angle X-ray scattering and chemical cross-linking. Biochemistry. 52:1568–82. doi:10.1021/bi301570m.
A randomized clinical trial of a web-based tobacco cessation education program.
Gordon JS, Mahabee-Gittens EM, Andrews JA, Christiansen SM, Byron DJ. 2013. A randomized clinical trial of a web-based tobacco cessation education program. Pediatrics. 131:e455–62. doi:10.1542/peds.2012-0611.
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
Algotar AM, Stratton MS, Ahmann FR, Ranger-Moore J, Nagle RB, Thompson PA, Slate E, Hsu CH, Dalkin BL, Sindhwani P, et al. 2013. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate. 73:328–35. doi:10.1002/pros.22573.